Eastern Mediterranean (WHO region) vs Kazakhstan: Hypertension treatment coverage among adults aged 30-79 with
Eastern Mediterranean (WHO region)
38.7%
in 2019
Kazakhstan
70.5%
in 2019
Eastern Mediterranean (WHO region) rank
6th
Kazakhstan rank
4th
Hypertension treatment coverage among adults aged 30-79 with over time
- Eastern Mediterranean (WHO region)
- Kazakhstan
How they compare
Kazakhstan currently reports 70.5% against 38.7% in Eastern Mediterranean (WHO region), a difference of 31.8%.
That makes Kazakhstan's figure about 1.8 times Eastern Mediterranean (WHO region)'s.
Across all 30 years both countries report, Kazakhstan has been ahead every year.
Eastern Mediterranean (WHO region) ranks 6th and Kazakhstan ranks 4th of 11 groups.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.7% | 43.9% | 21.2% | Kazakhstan |
| 2000s | 30.9% | 56.8% | 25.9% | Kazakhstan |
| 2010s | 37.5% | 67.2% | 29.6% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, Eastern Mediterranean (WHO region) or Kazakhstan?
- Kazakhstan, at 70.5% against 38.7% in Eastern Mediterranean (WHO region) as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between Eastern Mediterranean (WHO region) and Kazakhstan?
- 31.8%, with Kazakhstan ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Kazakhstan?
- 30 years are reported by both, from 1990 to 2019.
- How do Eastern Mediterranean (WHO region) and Kazakhstan rank globally for hypertension treatment coverage among adults aged 30-79 with?
- Eastern Mediterranean (WHO region) ranks 6th and Kazakhstan ranks 4th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.